Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2024-09-19

Clinical Trial Update: A Study of MK-0616 in Healthy Adult Participants (MK-0616-009) [Phase 1]

View source ↗

Summary

Phase 1 clinical trial update for MK-0616 in healthy adult participants. The study lists hypercholesterolemia as the associated condition and has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • MK-0616

Snippet

Sponsor: Merck Sharp & Dohme LLC | Conditions: Hypercholesterolemia | Phase 1 | Status: COMPLETED